$60.43▾ 0.02%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 176% above our fair-value range
Value-trap risk
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Eton Pharmaceuticals, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference